1. Home
  2. ARCT vs NDMO Comparison

ARCT vs NDMO Comparison

Compare ARCT & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • NDMO
  • Stock Information
  • Founded
  • ARCT 2013
  • NDMO 2019
  • Country
  • ARCT United States
  • NDMO United States
  • Employees
  • ARCT N/A
  • NDMO N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • NDMO Trusts Except Educational Religious and Charitable
  • Sector
  • ARCT Health Care
  • NDMO Finance
  • Exchange
  • ARCT Nasdaq
  • NDMO Nasdaq
  • Market Cap
  • ARCT 320.8M
  • NDMO 620.6M
  • IPO Year
  • ARCT N/A
  • NDMO N/A
  • Fundamental
  • Price
  • ARCT $18.05
  • NDMO $10.34
  • Analyst Decision
  • ARCT Strong Buy
  • NDMO
  • Analyst Count
  • ARCT 10
  • NDMO 0
  • Target Price
  • ARCT $50.88
  • NDMO N/A
  • AVG Volume (30 Days)
  • ARCT 493.8K
  • NDMO 218.6K
  • Earning Date
  • ARCT 11-06-2025
  • NDMO 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • NDMO 6.75%
  • EPS Growth
  • ARCT N/A
  • NDMO N/A
  • EPS
  • ARCT N/A
  • NDMO N/A
  • Revenue
  • ARCT $122,122,000.00
  • NDMO N/A
  • Revenue This Year
  • ARCT N/A
  • NDMO N/A
  • Revenue Next Year
  • ARCT $28.92
  • NDMO N/A
  • P/E Ratio
  • ARCT N/A
  • NDMO N/A
  • Revenue Growth
  • ARCT N/A
  • NDMO N/A
  • 52 Week Low
  • ARCT $8.04
  • NDMO $8.99
  • 52 Week High
  • ARCT $25.88
  • NDMO $11.24
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 58.87
  • NDMO 66.25
  • Support Level
  • ARCT $16.54
  • NDMO $10.36
  • Resistance Level
  • ARCT $19.50
  • NDMO $9.98
  • Average True Range (ATR)
  • ARCT 1.08
  • NDMO 0.12
  • MACD
  • ARCT -0.08
  • NDMO 0.04
  • Stochastic Oscillator
  • ARCT 56.46
  • NDMO 80.56

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.

Share on Social Networks: